A股異動丨掌閲科技漲停 春節人均閲讀時長為去年同期3倍
格隆匯2月20日丨掌閲科技(603533.SH)漲停,報18.28元,總市值73.3億元。近日,掌閲發佈了春節防疫期間閲讀相關數據。數據顯示,今年大年三十至正月十五期間,人均閲讀時長是去年同期的3倍,《新型冠狀病毒感染防護》躍居閲讀榜單榜首。廣東、河南、湖北等受疫情影響較嚴重的省份各城市閲讀活躍度較高。掌閲科技主營業務為互聯網數字閲讀服務及增值服務業務,以出版社、版權機構、文學網站、作家為正版圖書數字內容來源,對數字圖書內容進行編輯製作和聚合管理,面向互聯網發行數字閲讀產品,同時從事網絡原創文學版權運營,電子書閲讀器硬件產品研發及銷售,基於自有互聯網平台的遊戲聯運、廣告營銷等增值服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.